BioSpace News Archive

Serological tests measure the amount of antibodies or proteins present in the blood when the body is responding to a specific infection, like COVID-19.

Mersana Therapeutics, Inc. announced that it has raised gross proceeds of approximately $65 million through its At-the-Market facility with participation based on interest received from Avoro Capital Advisors LLC, Bain Capital Life Sciences, Consonance Capital Investors and David Mott, Mersana’s Chairman of the Board.

Global Medical Ventilator Market: Increasing incidences of respiratory failure, rise in healthcare expenditure and surge in number of chronic disordersdriving the growth of the medical ventilator market.

Neogen Corporation (Nasdaq: NEOG) announced today that the U.S. Environmental Protection Agency (EPA) has expedited the approval of two additional disinfectants offered by the company that can be used in the fight against the novel coronavirus that causes COVID-19.

Many companies searching for an effective therapy or vaccine for the present world health crisis are focusing on creating a vaccine from the immune system.

Vivera Pharmaceuticals Launches Vivera Cares Matching Donation Program Designed to Expand Access to COV-2 Rapid COVID-19 Diagnostic Tests to State and Governmental Organizations in Need

SenesTech, Inc. announced the Company’s support of the efforts by community health officials and business leaders to respond with aggressive programs to control high rat populations that are emerging during the COVID-19 pandemic.

Vertex Pharmaceuticals Incorporated announced that the Vertex Foundation, a nonprofit charitable foundation, commits to make donations totaling $5 million in 2020 to support global COVID-19 relief efforts, including doubling its match for employees’ charitable donations to eligible organizations responding to the COVID-19 pandemic.

OrthoSensor, Inc., a leader in sensor-assisted technology for total joint replacement, announced today it has received a 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Alignment capabilities with VERASENSE™ Sensor-Assisted Technology, (VERASENSE),

COLCORONA trial to examine whether colchicine can reduce complications associated with COVID-19, slow disease progression, and save patient lives